Study of Ambrisentan in Participants With Pulmonary Hypertension

Clinical trial NCT00777920 · COMPLETED

Trial details

NCT number: NCT00777920
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2008-11-17
Primary completion: 2019-09-11
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.